NCT03954717View on ClinicalTrials.gov

Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
Multiple Sclerosis
Interventions
BEHAVIORAL

Shepherd CAN DO Program

CAN DO Shepherd is a four-day participatory program held at the Shepherd Center, in Atlanta, Georgia or people with MS. The four-day program comprises evidence-based, comprehensive, and personalized educational and experiential opportunities aimed at empowering and enabling a person with MS to live a health life beyond their MS.

Trial Locations (1)

30303

Shepherd Center, Atlanta

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

collaborator

Can Do Multiple Sclerosis

UNKNOWN

lead

Shepherd Center, Atlanta GA

OTHER

NCT03954717 - Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program | Biotech Hunter | Biotech Hunter